Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118682063 | 11868206 | 3 | F | 20081029 | 20160629 | 20151224 | 20160707 | EXP | US-ASTRAZENECA-2012SE74357 | ASTRAZENECA | 21102.00 | DY | M | Y | 85.70000 | KG | 20160707 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118682063 | 11868206 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | TABLET | ||||||||
| 118682063 | 11868206 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | TABLET | ||||||||
| 118682063 | 11868206 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10.0MG UNKNOWN | U | U | 21366 | 10 | MG | TABLET | |||||
| 118682063 | 11868206 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | UNKNOWN | U | U | 21366 | TABLET | |||||||
| 118682063 | 11868206 | 5 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | 0 | 30 | MG | TABLET | QD | ||||||||
| 118682063 | 11868206 | 6 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 | 12.5 | MG | TABLET | QD | ||||||||
| 118682063 | 11868206 | 7 | C | PLAVIX/CLOPIDOGREL | 2 | 0 | 71 | MG | TABLET | QD | |||||||||
| 118682063 | 11868206 | 8 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | 60 | MG | CAPSULE | QD | ||||||||
| 118682063 | 11868206 | 9 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | 3.125 | MG | TABLET | BID | ||||||||
| 118682063 | 11868206 | 10 | C | ASPIRIN. | ASPIRIN | 1 | 0 | 81 | MG | TABLET | QD | ||||||||
| 118682063 | 11868206 | 11 | C | ABILIFY | ARIPIPRAZOLE | 1 | 0 | 5 | MG | TABLET | QD | ||||||||
| 118682063 | 11868206 | 12 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 118682063 | 11868206 | 13 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 118682063 | 11868206 | 14 | C | AVODART | DUTASTERIDE | 1 | 0 | .5 | MG | CAPSULE | QD | ||||||||
| 118682063 | 11868206 | 15 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | 10 | MG | TABLET | QD | ||||||||
| 118682063 | 11868206 | 16 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | 20 | MG | TABLET | BID | ||||||||
| 118682063 | 11868206 | 17 | C | RAMIPRIL. | RAMIPRIL | 1 | 0 | 2.5 | MG | CAPSULE | QD | ||||||||
| 118682063 | 11868206 | 18 | C | TAMSULOSIN HCL | TAMSULOSIN | 1 | 0 | .4 | MG | CAPSULE | QD | ||||||||
| 118682063 | 11868206 | 19 | C | NAPROXEN. | NAPROXEN | 1 | 0 | 500 | MG | TABLET | BID | ||||||||
| 118682063 | 11868206 | 20 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 0 | 100 | MG | CAPSULE | TID | ||||||||
| 118682063 | 11868206 | 21 | C | CYCLOBENZAPRINE HCL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0 | 10 | MG | TABLET | QD | ||||||||
| 118682063 | 11868206 | 22 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | 18 | UG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118682063 | 11868206 | 1 | Blood cholesterol increased |
| 118682063 | 11868206 | 2 | Blood cholesterol increased |
| 118682063 | 11868206 | 3 | Blood cholesterol increased |
| 118682063 | 11868206 | 4 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118682063 | 11868206 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118682063 | 11868206 | Acute myocardial infarction | |
| 118682063 | 11868206 | Arteriosclerosis coronary artery | |
| 118682063 | 11868206 | Carotid artery occlusion | |
| 118682063 | 11868206 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118682063 | 11868206 | 1 | 2006 | 0 | ||
| 118682063 | 11868206 | 2 | 200801 | 201305 | 0 | |
| 118682063 | 11868206 | 3 | 20081008 | 0 | ||
| 118682063 | 11868206 | 4 | 201401 | 0 | ||
| 118682063 | 11868206 | 5 | 2006 | 0 | ||
| 118682063 | 11868206 | 6 | 20100217 | 0 | ||
| 118682063 | 11868206 | 7 | 2006 | 0 | ||
| 118682063 | 11868206 | 8 | 2006 | 0 | ||
| 118682063 | 11868206 | 9 | 20100315 | 0 | ||
| 118682063 | 11868206 | 10 | 2006 | 0 | ||
| 118682063 | 11868206 | 11 | 20110622 | 0 | ||
| 118682063 | 11868206 | 13 | 2006 | 2010 | 0 | |
| 118682063 | 11868206 | 14 | 20100115 | 0 | ||
| 118682063 | 11868206 | 15 | 20100115 | 0 | ||
| 118682063 | 11868206 | 16 | 20100115 | 0 | ||
| 118682063 | 11868206 | 17 | 20100115 | 0 | ||
| 118682063 | 11868206 | 18 | 20100115 | 0 | ||
| 118682063 | 11868206 | 19 | 20100714 | 0 | ||
| 118682063 | 11868206 | 20 | 20111013 | 0 | ||
| 118682063 | 11868206 | 21 | 20120531 | 0 | ||
| 118682063 | 11868206 | 22 | 20121017 | 0 |